About this trial
Brain tumors are the second most frequent malignant diseases in children and adolescents. In the study the short and medium term consequences of proton therapy on cognitive processes in particular on executive functions in pediatric patients shall be highlighted/analysed/evalutated. In a second step, these results are to be compared with
1. a group of children and adolescents who had only /exclusively had operative therapy and 2. with a healthy control group. Thus, the extent to which these treatment options differ in terms of their short and medium-term effect is assessed. Methods of neurocognitive/neurophysiology brain research approaches are applied that may potentially visualize even small / subtle changes in mental activities/neurocognitive function. Therefore the effects of treatment can be evaluated and the neuropsychological outcome of children and adolescents with brain tumors can be improved.
Eligibility criteria
Qualifiers
all groups: Patients in childhood and adolescence between 8-18 years of age
all groups: no prior radiotherapy of the brain,
all groups: The patient is able to perform repeated neuropsychological tests (approx. 1 hour per examination),
all groups: corrected visual acuity not impaired below 80% or no subjective indication of visual acuity impairment,
Disqualifiers
Patients under 8 or over 18 years of age (We limit the study to children over 8 years of age due to the fact that executive functions mature very late.)
Brain metastases from extracerebral tumors
Patient receives intrathecal chemotherapy
pure palliative treatment concept
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Technische Universität Dresden
Lead sponsor
Gert und Susanna Mayer Stiftung
Collaborator